Comparative immunogenicity and safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine and 4vHPV vaccine administered according to two- or three-dose schedules in girls aged 9-14â¯years: Results to month 36 from a randomized trial
Keywords: 2D; 2-dose; 3D; 3-dose; AAHS; aluminum hydroxyphosphate sulphate; AE; adverse event; ANOVA; analysis of variance; AS04; Adjuvant System containing 50 µg 3-O-desacyl-4â²-monophosphoryl lipid A (MPL) adsorbed on aluminum salt (500 µg Al3+); ATP; accordin